<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font18 { font-size : 18; } .font25 { font-size : 25; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font25">and </span>
   <span class="font18">with </span>
   <span class="font15">was </span>
   <span class="font15">[]. </span>
   <span class="font15">vitro </span>
   <span class="font13">virus </span>
   <span class="font13">against </span>
   <span class="font13">for </span>
   <span class="font12">treatment </span>
   <span class="font12">antiviral </span>
   <span class="font12">that </span>
   <span class="font12">replication </span>
   <span class="font12">multifocal </span>
   <span class="font12">viral </span>
   <span class="font12">activity </span>
   <span class="font12">The </span>
   <span class="font12">human </span>
   <span class="font11">leukoencephalopathy </span>
   <span class="font11">effect </span>
   <span class="font11">were </span>
   <span class="font11">are </span>
   <span class="font11">not </span>
   <span class="font11">infection </span>
   <span class="font11">progressive </span>
   <span class="font11">{background </span>
   <span class="font11">used </span>
   <span class="font11">been </span>
   <span class="font11">cells </span>
   <span class="font11">patients </span>
   <span class="font11">Mefloquine </span>
   <span class="font11">cell </span>
   <span class="font11">different </span>
   <span class="font11">antimalarial </span>
   <span class="font11">Chloroquine </span>
   <span class="font11">other </span>
   <span class="font11">use </span>
   <span class="font11">drugs </span>
   <span class="font11">combination </span>
   <span class="font11">drug </span>
   <span class="font11">have </span>
   <span class="font11">margin </span>
   <span class="font11">vivo </span>
   <span class="font11">effects </span>
   <span class="font11">{border-style </span>
   <span class="font11">ART </span>
   <span class="font11">also </span>
   <span class="font11">but </span>
   <span class="font11">has </span>
   <span class="font11">infected </span>
   <span class="font10">Artesunate </span>
   <span class="font10">HIV </span>
   <span class="font10">patient </span>
   <span class="font10">px;} </span>
   <span class="font10">results </span>
   <span class="font10">study </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">after </span>
   <span class="font10">malaria </span>
   <span class="font10">therapy </span>
   <span class="font10">treated </span>
   <span class="font10">HCMV </span>
   <span class="font10">disease </span>
   <span class="font10">from </span>
   <span class="font10">inhibition </span>
   <span class="font10">such </span>
   <span class="font10">Clin. </span>
   <span class="font10">DENV </span>
   <span class="font10">[,] </span>
   <span class="font10">cytomegalovirus </span>
   <span class="font10">due </span>
   <span class="font10">its </span>
   <span class="font10">showed </span>
   <span class="font10">PML </span>
   <span class="font10">[,]. </span>
   <span class="font10">efficacy </span>
   <span class="font10">model </span>
   <span class="font10">Artemisinin </span>
   <span class="font10">Infect. </span>
   <span class="font10">artesunate </span>
   <span class="font10">confirmed </span>
   <span class="font10">demonstrated </span>
   <span class="font10">studies </span>
   <span class="font10">DOX </span>
   <span class="font10">HIV- </span>
   <span class="font10">Virus </span>
   <span class="font10">chloroquine </span>
   <span class="font10">clinical </span>
   <span class="font10">mefloquine </span>
   <span class="font10">outcome </span>
   <span class="font10">this </span>
   <span class="font10">which </span>
   <span class="font10">CHIKV </span>
   <span class="font10">Med. </span>
   <span class="font10">NCT </span>
   <span class="font10">Res../j.antiviral... </span>
   <span class="font10">case </span>
   <span class="font10">colleagues </span>
   <span class="font10">quinine </span>
   <span class="font10">some </span>
   <span class="font10">sulfate </span>
   <span class="font10">tested </span>
   <span class="font10">than </span>
   <span class="font10">However, </span>
   <span class="font10">Neurol. </span>
   <span class="font10">activities </span>
   <span class="font10">compared </span>
   <span class="font10">conducted </span>
   <span class="font10">derivatives </span>
   <span class="font10">infections </span>
   <span class="font10">micromolar </span>
   <span class="font10">mirtazapine </span>
   <span class="font10">only </span>
   <span class="font10">reduced </span>
   <span class="font10">viruses </span>
   <span class="font10">Doxycycline </span>
   <span class="font10">IAV </span>
   <span class="font10">Multifocal </span>
   <span class="font10">able </span>
   <span class="font10">active </span>
   <span class="font10">antiretroviral </span>
   <span class="font10">compounds </span>
   <span class="font10">dengue </span>
   <span class="font10">emerging </span>
   <span class="font10">hydroxyCQ </span>
   <span class="font10">inhibited </span>
   <span class="font10">number </span>
   <span class="font10">potential </span>
   <span class="font10">these </span>
   <span class="font10">(Table </span>
   <span class="font10">EBOV </span>
   <span class="font10">Ebola </span>
   <span class="font10">HCV </span>
   <span class="font10">JCPyV </span>
   <span class="font10">ONEe./journal.pone. </span>
   <span class="font10">RNA </span>
   <span class="font10">Res. </span>
   <span class="font10">This </span>
   <span class="font10">associated </span>
   <span class="font10">both </span>
   <span class="font10">cells, </span>
   <span class="font10">could </span>
   <span class="font10">data </span>
   <span class="font10">drug, </span>
   <span class="font10">effective </span>
   <span class="font10">hepatitis </span>
   <span class="font10">herpesvirus </span>
   <span class="font10">immune </span>
   <span class="font10">immunodeficiency </span>
   <span class="font10">influenza </span>
   <span class="font10">mechanisms </span>
   <span class="font10">mice </span>
   <span class="font10">published </span>
   <span class="font10">px; </span>
   <span class="font10">reported </span>
   <span class="font10">stem </span>
   <span class="font10">strains </span>
   <span class="font10">trials </span>
   <span class="font10">two </span>
   <span class="font10">when </span>
   <span class="font10">{font-family </span>
   <span class="font10">Agents </span>
   <span class="font10">Case </span>
   <span class="font10">Clinical </span>
   <span class="font10">Hydroxychloroquine </span>
   <span class="font10">Leukoencephalopathy </span>
   <span class="font10">S.D. </span>
   <span class="font10">[,,] </span>
   <span class="font10">acute </span>
   <span class="font10">al. </span>
   <span class="font10">artemisinin </span>
   <span class="font10">doxycycline </span>
   <span class="font10">entry </span>
   <span class="font10">font-size </span>
   <span class="font10">inhibit </span>
   <span class="font10">inhibits </span>
   <span class="font10">into </span>
   <span class="font10">load </span>
   <span class="font10">many </span>
   <span class="font10">observed </span>
   <span class="font10">potent </span>
   <span class="font10">reduction </span>
   <span class="font10">report </span>
   <span class="font10">resolution </span>
   <span class="font10">showing </span>
   <span class="font10">synthesis </span>
   <span class="font10">transplant </span>
   <span class="font10">trial </span>
   <span class="font10">using </span>
   <span class="font10">... </span>
   <span class="font10">Amodiaquine </span>
   <span class="font10">Chemother../AAC.- </span>
   <span class="font10">HIV-infected </span>
   <span class="font10">Med../internalmedicine.. </span>
   <span class="font10">Quinine </span>
   <span class="font10">Table </span>
   <span class="font10">They </span>
   <span class="font10">[,,]. </span>
   <span class="font10">action </span>
   <span class="font10">activation </span>
   <span class="font10">agents </span>
   <span class="font10">anti-HIV- </span>
   <span class="font10">assay </span>
   <span class="font10">cells. </span>
   <span class="font10">cervical </span>
   <span class="font10">combined </span>
   <span class="font10">concentrations </span>
   <span class="font10">decrease </span>
   <span class="font10">described </span>
   <span class="font10">double; </span>
   <span class="font10">drugs. </span>
   <span class="font10">evaluated </span>
   <span class="font10">first </span>
   <span class="font10">had </span>
   <span class="font10">hydroxychloroquine </span>
   <span class="font10">infection, </span>
   <span class="font10">low </span>
   <span class="font10">more </span>
   <span class="font10">new </span>
   <span class="font10">one </span>
   <span class="font10">positive </span>
   <span class="font10">range </span>
   <span class="font10">reducing </span>
   <span class="font10">risperidone </span>
   <span class="font10">several </span>
   <span class="font10">shown </span>
   <span class="font10">suggested </span>
   <span class="font10">their </span>
   <span class="font10">Fatal </span>
   <span class="font10">Finally, </span>
   <span class="font10">HIV-positive </span>
   <span class="font10">HPV </span>
   <span class="font10">Neurovirol../s--- </span>
   <span class="font10">One </span>
   <span class="font10">Other </span>
   <span class="font10">References </span>
   <span class="font10">Sulfonamides </span>
   <span class="font10">VSV </span>
   <span class="font10">Vero </span>
   <span class="font10">Virol../j.jcv... </span>
   <span class="font10">Viruses </span>
   <span class="font10">ZIKV </span>
   <span class="font10">Zika </span>
   <span class="font10">[,,,] </span>
   <span class="font10">[], </span>
   <span class="font10">although </span>
   <span class="font10">between </span>
   <span class="font10">blood </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">cancer </span>
   <span class="font10">care </span>
   <span class="font10">caused </span>
   <span class="font10">chikungunya </span>
   <span class="font10">chronic </span>
   <span class="font10">death </span>
   <span class="font10">decreased </span>
   <span class="font10">did </span>
   <span class="font10">drugs, </span>
   <span class="font10">during </span>
   <span class="font10">evaluation </span>
   <span class="font10">few </span>
   <span class="font10">group </span>
   <span class="font10">high </span>
   <span class="font10">infection. </span>
   <span class="font10">inhibitory </span>
   <span class="font10">known </span>
   <span class="font10">leukoencephalopathy: </span>
   <span class="font10">literature </span>
   <span class="font10">obtained </span>
   <span class="font10">outcomes </span>
   <span class="font10">phase </span>
   <span class="font10">placebo </span>
   <span class="font10">plaque </span>
   <span class="font10">randomized </span>
   <span class="font10">regarding </span>
   <span class="font10">review </span>
   <span class="font10">severe </span>
   <span class="font10">significant </span>
   <span class="font10">solid; </span>
   <span class="font10">syndrome </span>
   <span class="font10">synergism </span>
   <span class="font10">type </span>
   <span class="font10">viruses, </span>
   <span class="font10">widely </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(Sarah </span>
   <span class="font10">(mouse) </span>
   <span class="font10">ART, </span>
   <span class="font10">Although </span>
   <span class="font10">Antimalarial </span>
   <span class="font10">Chinese </span>
   <span class="font10">DHA </span>
   <span class="font10">DNA </span>
   <span class="font10">Dihydroartemisinin </span>
   <span class="font10">Dis../ </span>
   <span class="font10">Drugs </span>
   <span class="font10">Furthermore, </span>
   <span class="font10">HBV </span>
   <span class="font10">Health </span>
   <span class="font10">KSHV </span>
   <span class="font10">Moreover, </span>
   <span class="font10">These </span>
   <span class="font10">Treatment </span>
   <span class="font10">Virol../JVI.- </span>
   <span class="font10">[,,,,] </span>
   <span class="font10">activity, </span>
   <span class="font10">administration </span>
   <span class="font10">always </span>
   <span class="font10">analogs </span>
   <span class="font10">anti-cytomegalovirus </span>
   <span class="font10">based </span>
   <span class="font10">because </span>
   <span class="font10">bold </span>
   <span class="font10">can </span>
   <span class="font10">cases </span>
   <span class="font10">cases, </span>
   <span class="font10">chemical </span>
   <span class="font10">coronavirus </span>
   <span class="font10">courier; </span>
   <span class="font10">derivatives, </span>
   <span class="font10">difference </span>
   <span class="font10">difficult </span>
   <span class="font10">dimer </span>
   <span class="font10">diseases </span>
   <span class="font10">dose-dependent </span>
   <span class="font10">doses </span>
   <span class="font10">double-blind, </span>
   <span class="font10">drug-resistant </span>
   <span class="font10">either </span>
   <span class="font10">em; </span>
   <span class="font10">factors </span>
   <span class="font10">fever </span>
   <span class="font10">following </span>
   <span class="font10">four </span>
   <span class="font10">further </span>
   <span class="font10">herpes </span>
   <span class="font10">host </span>
   <span class="font10">improved </span>
   <span class="font10">improvement </span>
   <span class="font10">infectionJ. </span>
   <span class="font10">inhibitors </span>
   <span class="font10">latent </span>
   <span class="font10">malaria. </span>
   <span class="font10">measured </span>
   <span class="font10">microorganisms---t_Table </span>
   <span class="font10">might </span>
   <span class="font10">most </span>
   <span class="font10">multiple </span>
   <span class="font10">negative </span>
   <span class="font10">papillomavirus </span>
   <span class="font10">performed </span>
   <span class="font10">plasma </span>
   <span class="font10">polyomavirus </span>
   <span class="font10">possible </span>
   <span class="font10">present </span>
   <span class="font10">prevent </span>
   <span class="font10">primary </span>
   <span class="font10">production </span>
   <span class="font10">progression </span>
   <span class="font10">proposed </span>
   <span class="font10">pt;} </span>
   <span class="font10">recent </span>
   <span class="font10">reports </span>
   <span class="font10">resistance </span>
   <span class="font10">risk </span>
   <span class="font10">same </span>
   <span class="font10">serious </span>
   <span class="font10">since </span>
   <span class="font10">standard </span>
   <span class="font10">strain </span>
   <span class="font10">sulfonamides </span>
   <span class="font10">systematic </span>
   <span class="font10">targeting </span>
   <span class="font10">therapeutic </span>
   <span class="font10">they </span>
   <span class="font10">third </span>
   <span class="font10">those </span>
   <span class="font10">traditional </span>
   <span class="font10">treat </span>
   <span class="font10">valacyclovir </span>
   <span class="font10">versus </span>
   <span class="font10">who </span>
  </p>
 </body>
</html>
